These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 39009456)

  • 21. Simulation-based training improves process times in acute stroke care (STREAM).
    Bohmann FO; Gruber K; Kurka N; Willems LM; Herrmann E; du Mesnil de Rochemont R; Scholz P; Rai H; Zickler P; Ertl M; Berlis A; Poli S; Mengel A; Ringleb P; Nagel S; Pfaff J; Wollenweber FA; Kellert L; Herzberg M; Koehler L; Haeusler KG; Alegiani A; Schubert C; Brekenfeld C; Doppler CEJ; Onur ÖA; Kabbasch C; Manser T; Steinmetz H; Pfeilschifter W;
    Eur J Neurol; 2022 Jan; 29(1):138-148. PubMed ID: 34478596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of an intrahospital mobile thrombolysis team on 3-month clinical outcomes in patients benefiting from intravenous thrombolysis for acute ischemic stroke.
    Hebant B; Triquenot-Bagan A; Guegan-Massardier E; Ozkul-Wermester O; Grangeon L; Maltête D
    Rev Neurol (Paris); 2017 Mar; 173(3):152-158. PubMed ID: 28314516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Door-to-needle time for thrombolysis: a secondary analysis of the TIPS cluster randomised controlled trial.
    Hasnain MG; Paul CL; Attia JR; Ryan A; Kerr E; D'Este C; Hall A; Milton AH; Hubbard IJ; Levi CR
    BMJ Open; 2019 Dec; 9(12):e032482. PubMed ID: 31843839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positive impact of the participation in the ENCHANTED trial in reducing Door-to-Needle Time.
    Yang J; Wang X; Yu JP; Hang J; Lavados P; Robinson T; Arima H; Lindley RI; Anderson CS; Chalmers J
    Sci Rep; 2017 Oct; 7(1):14168. PubMed ID: 29074964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of extended door-to-needle time in acute ischemic stroke and its influence on in-hospital mortality: results of a nationwide Dutch clinical audit.
    Kuhrij LS; Marang-van de Mheen PJ; van den Berg-Vos RM; de Leeuw FE; Nederkoorn PJ;
    BMC Neurol; 2019 Nov; 19(1):265. PubMed ID: 31684901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of prehospital intervention based on emergency medical services on door-to-needle time of thrombolysis in acute ischemic stroke].
    Wang Y; Zhang C; Sun W; Hu X; Lyu Z; Liu W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):667-670. PubMed ID: 30045795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of intravenous thrombolysis time and prognosis in patients with in-hospital stroke].
    Zhang C; Lou M; Chen Z; Chen H; Xu D; Wang Z; Hu H; Wu C; Zhang X; Ma X; Wang Y; Hu H
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2019 May; 48(3):260-266. PubMed ID: 31496157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of organisational management on door-to-needle times for fibrinolytic treatment.
    Vicente-Pascual M; Quilez A; Gil MP; González-Mingot C; Vázquez-Justes D; Mauri-Capdevila G; Sanahuja J; García-Vázquez C; Purroy F
    Neurologia (Engl Ed); 2023 Jun; 38(5):313-318. PubMed ID: 35842131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility of using magnetic resonance imaging as a screening tool for acute stroke thrombolysis.
    Sakamoto Y; Tanabe M; Masuda K; Ozaki H; Okubo S; Suda S; Abe A; Aoki J; Muraga K; Kanamaru T; Suzuki K; Katano T; Kimura K
    J Neurol Sci; 2016 Sep; 368():168-72. PubMed ID: 27538625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal Trends in Clinical Characteristics and Door-to-Needle Time in Patients Receiving Intravenous Tissue Plasminogen Activator: A Retrospective Study of 4 Hospitals in Japan.
    Tanaka K; Matsumoto S; Yamada T; Nagano S; Takase KI; Hatano T; Yamasaki R; Kira JI
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104305. PubMed ID: 31405791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temporal sustainability of guideline based door-to-needle times for intravenous thrombolysis for acute ischemic stroke.
    Raina A; Trivedi M; Kate M; Kumar L; Erat Sreedharan S; Sylaja PN
    J Clin Neurosci; 2020 Apr; 74():164-167. PubMed ID: 32094070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement in Door-to-Needle Time in Patients with Acute Ischemic Stroke via a Simple Stroke Activation Protocol.
    Tan BYQ; Ngiam NJH; Sunny S; Kong WY; Tam H; Sim TB; Leong BSH; Bhartendu C; Paliwal PR; Seet RCS; Chan BPL; Teoh HL; Sharma VK; Yeo LLL
    J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1539-1545. PubMed ID: 29422380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measuring Quality Improvement in Acute Ischemic Stroke Care: Interrupted Time Series Analysis of Door-to-Needle Time.
    van Dishoeck AM; Dippel DW; Dirks M; Looman CW; Mackenbach JP; Steyerberg EW
    Cerebrovasc Dis Extra; 2014 Jan; 4(2):149-55. PubMed ID: 25076959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are All Stroke Patients Eligible for Fast Alteplase Treatment? An Analysis of Unavoidable Delays.
    Choi PM; Desai JA; Kashyap D; Stephenson C; Kamal N; Vogt S; Bohm V; Suddes M; Bugbee E; Hill MD; Demchuk AM; Smith EE
    Acad Emerg Med; 2016 Apr; 23(4):393-9. PubMed ID: 26824684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing in-hospital delay in treatment with intravenous thrombolysis.
    Mikulík R; Kadlecová P; Czlonkowska A; Kobayashi A; Brozman M; Svigelj V; Csiba L; Fekete K; Kõrv J; Demarin V; Vilionskis A; Jatuzis D; Krespi Y; Ahmed N;
    Stroke; 2012 Jun; 43(6):1578-83. PubMed ID: 22426311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between onset-to-door time and door-to-thrombolysis time: a pooled analysis of 10 dedicated stroke centers.
    Strbian D; Michel P; Ringleb P; Numminen H; Breuer L; Bodenant M; Seiffge DJ; Jung S; Obach V; Weder B; Tiainen M; Eskandari A; Gumbinger C; Gensicke H; Chamorro A; Mattle HP; Engelter ST; Leys D; Köhrmann M; Parkkila AK; Hacke W; Tatlisumak T
    Stroke; 2013 Oct; 44(10):2808-13. PubMed ID: 23887834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Network-Wide Stroke Team Program Reduces Time to Treatment for Endovascular Stroke Therapy in a Regional Stroke-Network.
    Bohmann FO; Tahtali D; Kurka N; Wagner M; You SJ; du Mesnil de Rochemont R; Berkefeld J; Hartmetz AK; Kuhlmann A; Lorenz MW; Schütz A; Kress B; Henke C; Tritt S; Meyding-Lamadé U; Steinmetz H; Pfeilschifter W
    Cerebrovasc Dis; 2018; 45(3-4):141-148. PubMed ID: 29587257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a multicomponent intervention to shorten thrombolytic door-to-needle time in stroke patients in China (MISSION): A cluster-randomized controlled trial.
    Zhong W; Lin L; Gong X; Chen Z; Chen Y; Yan S; Zhou Y; Zhang X; Hu H; Tong L; Cheng C; Gu Q; Chen Y; Yu X; Huang Y; Yuan C; Lou M;
    PLoS Med; 2022 Jul; 19(7):e1004034. PubMed ID: 35788767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Advanced treatment time improves outcomes of patients with ischemic stroke undergoing reperfusion therapy].
    Chen H; Gong X; Xu D; Wang Z; Hu H; Wu C; Zhang X; Ma X; Wang Y; Hu H; Lou M; Chen Z
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2019 May; 48(3):247-253. PubMed ID: 31496155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in Door-to-Thrombolysis Time in the Safe Implementation of Stroke Thrombolysis Registry: Effect of Center Volume and Duration of Registry Membership.
    Strbian D; Ahmed N; Wahlgren N; Lees KR; Toni D; Roffe C; Surakka IL; Tatlisumak T;
    Stroke; 2015 May; 46(5):1275-80. PubMed ID: 25828238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.